✦ LIBER ✦

19 A Kent and Medway Cancer Network (KMCN) audit of first-line treatment with cisplatin/pemetrexed (CisPem) in non squamous non-small cell lung cancer (NSCLC)

✍ Scribed by Letsa, I.; Mikropoulos, C.; Burcombe, R.; Visioli, A.; Sevitt, T.; Cominos, M.; Beesley, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Kent and Medway Cancer Network (KMCN)

✍ Cafferkey, C.; Jamal-Hanjani, M.; Beesley, S.; Cominos, M.; Sevitt, T.; Taylor, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

43 Use of first line maintenance chemoth

✍ Stansfield, R.; Mohanamurali, J.; Danson, S.J.; Fisher, P.M.; Hatton, M.Q.; Lee, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

An indirect comparison of bevacizumab pl

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Bevacizumab combined with pemetrexed plu

✍ Santoro, Armando; Hillerdal, Gunnar N.; Hoeffken, Gert; Favaretto, Adolfo; Carri 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Vinorelbine, ifosfamide and cisplatin (N

✍ Teixeira, E; Sotto-Mayor, R; Borges, M; Bugalho de Almeida, A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

9083 POSTER Pemetrexed (PEM) Plus Platin

✍ Moscetti, L.; Fabbri, M.A.; Narducci, F.; Mansueto, G.; Longo, F.; Martelli, O.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB